L-Arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease
L-Arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease
复制标题
DOI:
10.1016/j.atherosclerosis.2008.08.034
复制
发表时间:
2009-05-01
期刊:
影响因子:
5.3
通讯作者:
Pernow, J.
中科院分区:
文献类型:
--
作者:
Settergren, M.;Bohm, F.;Pernow, J.
Diminished levels of L-arginine and endothelial nitric oxide synthase (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH4) May Contribute to endothelial dysfunction. We investigated the effect of L-arginine and BH4 administration on ischemia-reperfusion (I/R)-induced endothelial dysfunction in patients with type 2 diabetes and Coronary artery disease (CAD). Forearm blood flow was measured by venous occlusion plethysmography in 12 patients with type 2 diabetes or impaired glucose tolerance and CAD.Forearm ischemia was induced for 20 min, followed by 60 min of reperfusion. The patients received a 15 min intra-brachial infusion Of L-arginine (20 mg/min) and BH4 (500 mu g/min) or 0.9% saline starting at 15 min of ischemia on two separate study occasions. Compared with pre-ischemia the endothelium-dependent vasodilatation (EDV) induced by acetylcholine was significantly reduced at 15 and 30 min of reperfusion when saline was infused (P